Martin Bolin

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: EJNMMI PHYSICS. 2026;13(1):35
The impact of data driven motion correction for clinical brain PET/MRI radiotracers
Bolin M; Delgado AF; Palmer E
Journal article: NEUROSCIENCE APPLIED. 2026;5:106011
Synaptic density marker, SV2A, is reduced in autistic adults and a mouse model of idiopathic autism
Griffioen G; Mehra C; Petrinovic MM; Matheson G; Bolin M; Onwordi EC; Shatalina E; Kowalewska B; Martins R; Mouga S; Castelo-Branco M; Muircheartaigh J; Oliver H; Rodrigues AP; Natesan S; Andersson M; Neufeld J; Norrman HN; Lundin K; Bölte S; Borg J; Murphy D
Article: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2025;12(8):100302
Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers
Nery FC; Kaliszczak M; Suttle B; Jones L; Wu S; Xie J; Curiale G; Yesilalan E; Hirschhorn B; Wilkes D; Singh D; Bolin M; Nag S; Varrone A; Stenkrona P; Halldin C; Yachnin J; Arnold HM; Bullain S; Landen J; Gallagher D; Hering H
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025;45(8):1606-1616
In vivo quantification of [¹¹C]BIO-1819578 in non-human primates, a novel radioligand for O-GlcNAcase
Bolin M; Nag S; Arakawa R; Varrone A; Farde L; Martarello L; Kaliszczak MA; Halldin C; Moren AF
Article: MOLECULES. 2025;30(6):1356
Good Manufacturing Practice Validation and Radiation Dosimetry for the Clinical Application of a Novel α7-nAChR Radioligand: [¹¹C]KIn83
Jia Z; Bolin M; Moren AF; Datta P; Asem H; Agren H; Langstrom B; Nordberg A; Halldin C; Nag S
Article: PHARMACEUTICALS. 2025;18(2):135
Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [¹¹C]AZD2423
Dahl K; Johnstrom P; Toth M; Bolin M; Varnas K; Nakao R; Takano A; Khani Meynaq Y; Bayrakdarian M; Cselenyi Z; Halldin C; Farde L; Schou M
Journal article: JOURNAL OF NUCLEAR MEDICINE. 2023;64(10):1588-1593
Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain.
Cook BE; Nag S; Arakawa R; Lin EY-S; Stratman N; Guckian K; Hering H; Lulla M; Choi J; Salinas C; Genung NE; Morén AF; Bolin M; Boscutti G; Plisson C; Martarello L; Halldin C; Kaliszczak MA
Article: JOURNAL OF NUCLEAR MEDICINE. 2023;64(10):1588-1593
Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain
Cook BE; Nag S; Arakawa R; Lin EY-S; Stratman N; Guckian K; Hering H; Lulla M; Choi J; Salinas C; Genung NE; Moren AF; Bolin M; Boscutti G; Plisson C; Martarello L; Halldin C; Kaliszczak MA
Article: QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2023;67(3):215-222
¹¹C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction
De Luca F; Bolin M; Blomqvist L; Wassberg C; Martin H; Delgado AF
Article: ACS CHEMICAL NEUROSCIENCE. 2023;14(14):2560-2568
Development of a Novel [¹¹C]CO-Labeled Positron Emission Tomography Radioligand [¹¹C]BIO-1819578 for the Detection of O-GlcNAcase Enzyme Activity
Nag S; Bolin M; Datta P; Arakawa R; Moren AF; Maynaq YK; Lin E; Genung N; Hering H; Guckian K; Martarello L; Kaliszczak M; Halldin C
Article: FRONTIERS IN NUCLEAR MEDICINE. 2023;2:1080005
Proof of lung muscarinic receptor occupancy by tiotropium: Translational Positron Emission Tomography studies in non-human primates and humans
Cselenyi Z; Jucaite A; Ewing P; Stenkrona P; Kristensson C; Johnstrom P; Schou M; Bolin M; Halldin C; Larsson B; Grime K; Eriksson UG; Farde L
Journal article: NEUROSCIENCE APPLIED. 2023;2:101035
Glutamate 5 receptor availability differences in twins discordant for autism and controls, do shared genetics matter
Griffioen G; Andersson M; Tangen Ä; Bolin M; Farde L; Halldin C; Bölte S; Lundberg J; Borg J
Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:s26
O-37 Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity
Nag S; Arakawa R; Datta P; Morén A; Varrone A; Moein MM; Bolin M; Lin E; Genung N; Martarello L; Kaliszczak M; Halldin C
Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:s216-s217
P-307 Comparative in vivo biodistribution and dosimetry in non-human primate of the fibroblast activation protein radiotracers [68Ga]Ga-FAPI-04, [68Ga]Ga-FAPI-46 and [18F]FAPI-74
Tran T; Bolin M; Dahl K; Johnstrom P; Mitran B; Siikanen J; Schou M
Article: BMC MEDICAL IMAGING. 2020;20(1):126
Validation of PET/MRI attenuation correction methodology in the study of brain tumours
De Luca F; Bolin M; Blomqvist L; Wassberg C; Martin H; Delgado AF
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2020;47(10):2429-2439
PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [¹⁸F]PF-06684511
Arakawa R; Takano A; Stenkrona P; Stepanov V; Nag S; Jahan M; Gryback P; Bolin M; Chen L; Zhang L; He P; Villalobos A; McCarthy TJ; Halldin C; Varrone A
Article: EJNMMI RESEARCH. 2020;10(1):59
Quantification and reliability of [¹¹C]VC-002 binding to muscarinic acetylcholine receptors in the human lung - a test-retest PET study in control subjects
Cselenyi Z; Jucaite A; Kristensson C; Stenkrona P; Ewing P; Varrone A; Johnstrom P; Schou M; Vazquez-Romero A; Moein MM; Bolin M; Siikanen J; Gryback P; Larsson B; Halldin C; Grime K; Eriksson UG; Farde L

Alla övriga publikationer

Preprint: MEDRXIV. 2026
Multi-modal and multi-organ in vivo imaging to assess geroprotective interventions in humans: results from a pilot trial of rapamycin in Alzheimer’s Disease
Plavén-Sigray P; Bolin M; Palmér E; Dörfel R; Thor D; Schain M; Nilsson M; Golpour N; Brautaset R; Williams PA; Spin-Neto R; Probst M; Castaings J; Sörensson P; Marlevi D; Carlsson M; Kivipelto M; Svensson JE
Corrigendum: JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE. 2026;13(1):100425
Results of the first-in-human, randomized, double-blind, placebo-controlled, single-and multiple-ascending dose study of BIIB113 in healthy volunteers (vol12 , 100302 , 2025)
Nery FC; Kaliszczak M; Suttle B; Jones L; Wu S; Xie J; Curiale G; Yesilalan E; Hirschhorn B; Wilkes D; Singh D; Bolin M; Nag S; Varrone A; Stenkrona P; Moren AF; Halldin C; Yachnin J; Arnold HM; Bullain S; Landen J; Gallagher D; Hering H
Preprint: MEDRXIV. 2025
Evaluation of rapamycin as a neuroprotective treatment in Alzheimer’s disease: a six-month single-arm open-label clinical pilot trial
Svensson JE; Dörfel RP; Schain M; Bolin M; Sacuiu S; Hagman G; Morén AF; Kivipelto M; Plavén-Sigray P
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025;45(1):65-66
First in Man and Test-retest Evaluation of [11C]BIO-1819578, a Radioligand for O-GlcNAcase
Bolin M; Varrone A; Stenkrona P; Nag S; Farde L; Kaliszczak M; Martarello L; Halldin C; Moren AF
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2025;45(1):118-119
Evaluation of Data-Driven List-Mode Motion Estimation Techniques for Signal-Varying Dynamic PET Acquisitions
Bolin M; Cselenyi Z; Palmer E
Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2025;28:i35-i36
NO DIFFERENCES IN SYNAPTIC DENSITY IN TWINS WITH AUTISM AND THEIR NON-AUTISTIC CO-TWINS. HOWEVER, ARE DIFFERENCES IN SV2A BINDING POTENTIAL IN AUTISTIC BRAINS A MATTER OF WHITE MATTER?
Griffioen-Jarfalk G; Bolin M; Stephanov V; Cervenka S; Castelo-Branco M; Martins R; Lundberg J; Mehra C; Howes O; Murphy D; Bolte S; Farde L; Borg J
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024;51:S816-S817
GMP validation (CMC) and Radiation dosimetry for clinical application of a novel α7-nAChR radioligand: [¹¹C]Kln83
Jia K; Nag S; Datta P; Moren A; Bolin M; Asem H; Agren H; Langstrom B; Halldin C; Nordberg A
Study protocol: BMC NEUROLOGY. 2024;24(1):111
Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol
Svensson JE; Bolin M; Thor D; Williams PA; Brautaset R; Carlsson M; Sorensson P; Marlevi D; Spin-Neto R; Probst M; Hagman G; Moren AF; Kivipelto M; Plaven-Sigray P
Preprint: MEDRXIV. 2024
Evaluating the effect of rapamycin treatment in Alzheimer's Disease and aging usingin vivoimaging: the ERAP phase IIa clinical study protocol
Svensson J; Bolin M; Thor D; Williams P; Brautaset R; Carlsson M; Sörensson P; Marlevi D; Spin-Neto R; Probst M; Hagman G; Morén AF; Kivipelto M; Plavén-Sigray P
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2023;50(SUPPL 1):S257
In vivo quantification of [¹¹C]BIO-1819578, a novel radioligand for O-GlcNAcase, in non-human primates using Positron Emission Tomography
Bolin M; Nag S; Datta P; Arakawa R; Meynaq YK; Lin E; Genung N; Hering H; Guckian K; Martarello L; Kaliszczak M; Farde L; Stenkrona P; Halldin C; Moren AF
Preprint: RESEARCH SQUARE. 2022
Lung muscarinic receptor occupancy by tiotropium: translational Positron Emission Tomography studies in non-human primates and humans
Cselényi Z; Jucaite A; Ewing P; Stenkrona P; Kristensson C; Johnström P; Schou M; Bolin M; Halldin C; Larsson B; Grime K; Eriksson UG; Farde L
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2022;49(SUPPL 1):S238
Development of a novel ¹¹CO labelled PET radioligand ¹¹C-BIO-1819578 for the detection of O-GlcNAcase (OGA) enzyme in the living brain
Nag S; Arakawa R; Datta P; Forsberg A; Moein M; Bolin M; Lin T; Genung N; Heiring H; Guckian K; Martarello L; Kaliszczak M; Halldin C
Preprint: RESEARCH SQUARE. 2022
Lung muscarinic receptor occupancy by tiotropium: translational PET studies in non-human primates and humans
Cselényi Z; Jucaite A; Ewing P; Stenkrona P; Kristensson C; Johnström P; Schou M; Bolin M; Halldin C; Larsson B; Grime K; Eriksson UG; Farde L
Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S26
Synthesis and biological evaluation of a novel radioligand [¹¹C]BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity
Nag S; Arakawa R; Datta P; Moren A; Varrone A; Moein MM; Bolin M; Lin E; Genung N; Martarello L; Kaliszczak M; Halldin C
Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S216-S217
Comparative in vivo biodistribution and dosimetry in non-human primate of the fibroblast activation protein radiotracers [⁶⁸Ga]Ga-FAPI-04, [⁶⁸Ga]Ga-FAPI-46 and [¹⁸F]FAPI-74
Thuy T; Bolin M; Dahl K; Johnstrom P; Mitran B; Siikanen J; Schou M
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(SUPPL 1):S208-S209
Low dose CT for attenuation correction in PET. Validation of quantification for different patient sizes
Tornblom A; Siikanen J; Thor D; Bolin M
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2017;44:S172
Human Whole-body Biodistribution and Radiation Dosimetry of [¹⁸F]PF-06684511, a Novel Radioligand for Brain Imaging of Beta-secretase
Varrone A; Arakawa R; Takano A; Nag S; Stepanov V; Stenkrona P; Gryback P; Bolin M; Chen L; Zhang L; He P; Villalobos A; McCarthy T; Halldin C

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI